CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Farmácia e Bioquímica from Universidade Estadual de Londrina (2004), master's at Pharmacy from Universidade de São Paulo (2007) and doctorate at Ciências from Universidade de São Paulo (2011). Has experience in Pharmacy, acting on the following subjects: statins, prescrição, medicamento, gene expression and abca1. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Understanding the genetic factors involved in variations in responses to immunosuppressants can improve efficacy and limit toxicity in transplant therapy. This pharmacogenetic study aims to investigate associations between genetic polymorphisms that affect the pharmacokinetics of tacrolimus (TAC), everolimus (EVR), and mycophenolate sodium (MPS) and the clinical outcomes in kidney transpl…
What makes organ transplantation and the patient response to drug therapy especially complex is the nature of the drugs that are used, the number of polymorphic factors that play a role in drug responsiveness and the lack of understanding of the acute and chronic processes that jeopardize organ function and survival. Today, a major goal of immunosuppressive therapy is the individualized t…
ATP-binding cassette transporter A1 (ABCA1) is a transmembrane protein involved on cholesterol and phospholipids cellular efflux, which is an essential step for the cholesterol reverse transport. Polymorphisms in the ABCA1 gene have been associated with increased risk of coronary heart disease, differences on serum lipid profile and response to lowering-cholesterol drugs. Recently we have…
The narrow therapeutic index of the immunosuppressive drugs and the several factors influencing the pharmacological response contribute to make the patient monitoring especially complex in the organ transplantation. That is way, the individualization of treatment is an important tool that can contribute to the reduction of acute rejection events, improve efficacy and decrease the toxic or…
| 3 / 3 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 4 / 4 | All Scholarships |
| Associated processes | |